Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

  • Read more about StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

  • Read more about α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

Trial of 2nd Booster Dose of COVID-19 Vaccine

  • Read more about Trial of 2nd Booster Dose of COVID-19 Vaccine

Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

  • Read more about Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

  • Read more about PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Beta-glucans for Hospitalised Patients With COVID-19

  • Read more about Beta-glucans for Hospitalised Patients With COVID-19

An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19

  • Read more about An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

  • Read more about A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

  • Read more about LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients

  • Read more about Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Current page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA